Basal cell carcinoma (BCC) is the most common form of skin cancer. It is a slow-growing cancer that begins in the basal cells, which are located in the outermost layer of the skin. While BCC is not usually life-threatening, it can cause serious health problems if it is not treated promptly and properly. In this article, we will discuss the hidden dangers of BCC and what you need to know to protect yourself and your patients.
Basal cell carcinoma is a type of skin cancer that develops in the basal cells, which are located in the outermost layer of the skin. BCC is usually caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. It is most common in people with fair skin, but it can also occur in people with darker skin tones. BCC usually appears as a small, flesh-colored or pink bump on the skin. It may also be scaly, crusted, or have a sunken center.
There are certain risk factors that can increase your chances of developing BCC. These include: • Prolonged exposure to UV radiation from the sun or tanning beds. • A history of sunburns, especially in childhood. • Fair skin, light hair, and blue or green eyes. • A weakened immune system. • A history of skin cancer. • A family history of skin cancer.
If left untreated, BCC can spread to other parts of the body and cause serious complications. These include: • Disfigurement. BCC can cause scarring and disfigurement if it is not treated promptly. • Spread to other parts of the body. BCC can spread to other parts of the body, such as the lymph nodes and internal organs, if it is not treated promptly. • Metastasis. BCC can spread to other parts of the body, such as the lymph nodes and internal organs, if it is not treated promptly.
BCC is usually diagnosed through a physical examination and a biopsy. During a biopsy, a sample of the suspicious area is taken and examined under a microscope. If the biopsy confirms the presence of BCC, the doctor will recommend treatment. Treatment options for BCC include: • Surgery. Surgery is the most common treatment for BCC. It involves removing the cancerous cells and some of the surrounding tissue. • Radiation therapy. Radiation therapy uses high-energy X-rays to kill cancer cells. • Cryotherapy. Cryotherapy uses extreme cold to freeze and kill cancer cells. • Topical medications. Topical medications, such as imiquimod and 5-fluorouracil, can be used to treat BCC.
The best way to prevent BCC is to protect yourself from UV radiation. This can be done by: • Wearing protective clothing, such as long-sleeved shirts, long pants, and a wide-brimmed hat. • Applying sunscreen with an SPF of at least 30. • Avoiding direct sunlight, especially between 10am and 4pm. • Avoiding tanning beds.
Basal cell carcinoma is the most common form of skin cancer. While it is not usually life-threatening, it can cause serious health problems if it is not treated promptly and properly. It is important to be aware of the risk factors, complications, diagnosis, treatment, and prevention of BCC in order to protect yourself and your patients.
1.
Approved BTK Inhibitor Without Covalent Bond for CLL.
2.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
3.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
4.
Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.
5.
Brain cancer: a Q&A session.
1.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
2.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
3.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
4.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
5.
Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation